FT Options’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

FT Options’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.32M	Buy	71,000 +17,400	+32%	+$1.86M	1.99%	14
2017 Q2	$1.26M	Sell	53,600 -3,000	-5%	-$323K	2.17%	13
2017 Q1	$688K	Sell	56,600 -25,000	-31%	-$3.07M	0.91%	27
2016 Q4	$721K	Buy	81,600 +2,700	+3%	+$325K	0.83%	32
2016 Q3	$362K	Buy	78,900 +33,400	+73%	+$3.19M	0.29%	69
2016 Q2	$338K	Buy	45,500 +15,600	+52%	+$1.31M	0.29%	69
2016 Q1	$254K	Sell	29,900 -21,400	-42%	-$1.17M	0.27%	71
2015 Q4	$1.19M	Buy	+51,300	New	+$4.18M	0.88%	32

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FT Options's GWPH Position: Q3 2017 in Review

FT Options increased its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 9.8% in Q3 2017, buying an estimated $352K and bringing the position to 36,847 shares worth $3.74M. The position accounts for 5.64% of the portfolio, ranked #1.

FT Options first reported a position in GWPH in Q1 2017 and has held it in 3 quarters since. 181 funds tracked by Wall St. Rank hold GWPH as of Q3 2017.

FT Options held 36,847 shares of GW Pharmaceuticals Plc American Depositary Shares worth $3.74M as of Q3 2017.
FT Options bought 3,290 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2017, an estimated $352K.
GW Pharmaceuticals Plc American Depositary Shares made up 5.64% of FT Options's portfolio in Q3 2017, its #1 holding.
FT Options first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and has held it in 3 quarters since.
181 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.